lutetium has been researched along with arginyl-glycyl-aspartic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JK; Jeong, JM; Jeong, SY; Ju, CH; Kim, YJ; Lee, BC; Lee, DS; Lee, MC; Lee, YS | 1 |
| Bao, A; Cheng, Z; Cutler, CS; Jiang, L; Liu, H; Miao, Z; Ren, G; Shi, H | 1 |
| Chen, Y; Chong, HS; Kang, CS; Kweon, J; Lee, H; Lewis, MR; Liu, D; Sun, X | 1 |
| Bhusari, P; Kumar, R; Mittal, BR; Parihar, AS; Shukla, J; Sood, A | 1 |
4 other study(ies) available for lutetium and arginyl-glycyl-aspartic acid
| Article | Year |
|---|---|
Development of a ¹⁷⁷Lu-labeled RGD derivative for targeting angiogenesis.
Topics: Animal Structures; Animals; Chelating Agents; Chromatography, High Pressure Liquid; Colonic Neoplasms; Drug Delivery Systems; Drug Stability; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Kidney; Lutetium; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Neovascularization, Pathologic; Oligopeptides; Radioisotopes; Radiopharmaceuticals; Tissue Distribution | 2010 |
177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma.
Topics: Animals; Aza Compounds; Bombesin; Cell Line, Tumor; Dimerization; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Mice; Molecular Targeted Therapy; Oligopeptides; Prostatic Neoplasms; Radiation Dosage; Radiochemistry; Radioisotopes | 2013 |
Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Chemistry Techniques, Synthetic; Drug Stability; Glioblastoma; Heterocyclic Compounds; Humans; Isotope Labeling; Kinetics; Lutetium; Mice; Molecular Targeted Therapy; Oligopeptides; Tissue Distribution; Yttrium Radioisotopes | 2015 |
Novel use of
Topics: Carcinoma, Papillary; Female; Heterocyclic Compounds, 1-Ring; Humans; Iodine Radioisotopes; Lutetium; Middle Aged; Oligopeptides; Radioisotopes; Radionuclide Imaging; Thyroglobulin; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2018 |